Evidence map›Paper›PMID 38951065›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Pedigree Analysis and Molecular Mechanism Study of Hereditary Glanzmann Thrombasthenia Caused by Compound Heterozygous Mutation of the ITGA2B Gene].

X M Lu, D Y Fu, Y F Zhang, L D Zhao, L Wang, J Yang, J Liu, J W Zheng, L H Yang, G Wang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

X M LuInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
D Y FuInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
Y F ZhangInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
L D ZhaoInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
L WangInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
J YangInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
J LiuInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
J W ZhengInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
L H YangInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
G WangInstitute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.

Funding

National Natural Science Foundation of China 81700182Natural Science Foundation of Shanxi Province 20210302123295Science Technology Innovation Team of Shanxi Province 201605D131044-05
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HeterozygoteIntegrin alpha2MutationPedigreeThrombastheniaAdultFemaleGenotypeHumansMalePlatelet AggregationIntegrin alpha2ITGA2B protein, humanHereditary Glanzmann ThrombastheniaIntegrin αⅡbβ3ITGA2B GenemRNA SplicingNonsense Mutation

Identifiers

PMID38951065
PMCPMC11168003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.